Max Bachrach

Partner, Patent Attorney

Max is a partner at VHPM. Before joining the firm in 2023, Max was Vice President of Intellectual Property at Lexicon Pharmaceuticals, where he formulated and implemented patent, trademark, and life-cycle management strategies for Lexicon’s platform technologies, antibodies, antibody conjugates, and small molecule drug candidates. Before Lexicon, Max litigated and prosecuted patents for a variety of clients in the biotechnology and pharmaceutical industries. When not at work, Max enjoys spending time with his family, playing guitar, and running.

Max's favorite place to spend the summer: The Oregon coast

University of Virginia School of Law, J.D., 1998

California Institute of Technology, Ph.D., 1996

Columbia College, Columbia University, A.B., Chemistry, 1990

Wiedenfeld, D.; Bachrach, M.; McCleskey, T.M.; Hill, M.G.; Gray, H.B; and Winkler, J.R., “Temperature and Isotope Effects on the Rates of Photoinduced Iridium(I)‐Pyridinium Electron‐Transfer Reactions,” J. Phys. Chem. B, 101 (44), 8823‐8826, 1997.

Ponce, A.; Bachrach, M.; Farmer, P.J.; Winkler, J.R., “Intramolecular Electron Transfer in Cyanide-bridged Ruthenium Dimers,” Inorganica Chimica Acta, 243 (1-2), 135-140, 1996.

Han, R.; Bachrach, M.; Parkin, G., “Competitive Alkyl and Halide Metathesis in the Reactions of Grignard Reagents with Tl{η 3 -HB(3-Bu t pz) 3 },” Polyhedron, 9, 1775‐1778, 1990.